Growth dynamics in the biomedical/biotechnology system
Çetindamar, Dilek and Laage-Hellman, Jens (2003) Growth dynamics in the biomedical/biotechnology system. Small Business Economics, 20 (4). pp. 287-303. ISSN 0921-898X (Print) 1573-0913 (Online)
Full text not available from this repository.
Official URL: http://dx.doi.org/10.1023/A:1022959109782
This article aims to understand the dynamics of growth in the biomedical/biotechnology system that consists of a variety of actors ranging from universities, medical supplies firms, and drug research firms, to clinical service suppliers. Based on a comparative study made in Ohio and in Sweden, we have analyzed three main factors: technology competencies, technology transfer, and networking capabilities. Our findings show a set of differences that can be grouped into two categories, viz. management and agglomeration externalities. Differences in management appear at three points: the resources allocated to technological competence development, managerial skills in the technology transfer phase, and the use of technology councils. Ohio seems to offer a better environment for starting up new firms and enabling these firms to successfully commercialize their technological assets. The agglomeration externalities that make a difference between the two regions might be grouped into two categories: increasing returns arising from network externalities and the advantages of networking with a variety of supporting organizations in the system.
Repository Staff Only: item control page